nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—muscle cancer—peripheral nervous system neoplasm	0.237	0.556	CtDrD
Vincristine—sarcoma—peripheral nervous system neoplasm	0.189	0.444	CtDrD
Vincristine—NR0B1—Tretinoin—peripheral nervous system neoplasm	0.113	0.303	CbGbCtD
Vincristine—ABCB1—peripheral nervous system neoplasm	0.0866	1	CbGaD
Vincristine—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.038	0.102	CbGbCtD
Vincristine—RALBP1—Doxorubicin—peripheral nervous system neoplasm	0.0324	0.0871	CbGbCtD
Vincristine—ABCC10—Etoposide—peripheral nervous system neoplasm	0.0174	0.0469	CbGbCtD
Vincristine—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0119	0.0321	CbGbCtD
Vincristine—ABCC10—Doxorubicin—peripheral nervous system neoplasm	0.0119	0.032	CbGbCtD
Vincristine—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0115	0.031	CbGbCtD
Vincristine—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.0112	0.03	CbGbCtD
Vincristine—ABCC3—Etoposide—peripheral nervous system neoplasm	0.011	0.0295	CbGbCtD
Vincristine—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.00864	0.0232	CbGbCtD
Vincristine—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.00798	0.0215	CbGbCtD
Vincristine—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0079	0.0213	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0079	0.0213	CbGbCtD
Vincristine—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.00747	0.0201	CbGbCtD
Vincristine—ABCC1—Etoposide—peripheral nervous system neoplasm	0.00673	0.0181	CbGbCtD
Vincristine—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.00646	0.0174	CbGbCtD
Vincristine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.00593	0.0159	CbGbCtD
Vincristine—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.00507	0.0136	CbGbCtD
Vincristine—ABCC2—Etoposide—peripheral nervous system neoplasm	0.00498	0.0134	CbGbCtD
Vincristine—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.00459	0.0123	CbGbCtD
Vincristine—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00458	0.0123	CbGbCtD
Vincristine—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0045	0.0121	CbGbCtD
Vincristine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00415	0.0112	CbGbCtD
Vincristine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00415	0.0112	CbGbCtD
Vincristine—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0034	0.00914	CbGbCtD
Vincristine—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00307	0.00826	CbGbCtD
Vincristine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00288	0.00774	CbGbCtD
Vincristine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00249	0.00671	CbGbCtD
Vincristine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00249	0.00669	CbGbCtD
Vincristine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00231	0.00622	CbGbCtD
Vincristine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00165	0.00444	CbGbCtD
Vincristine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00162	0.00437	CbGbCtD
Vincristine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00298	CbGbCtD
Vincristine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.000973	0.00262	CbGbCtD
Vincristine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.00178	CbGbCtD
Vincristine—Voacamine—ABCB1—peripheral nervous system neoplasm	0.000606	0.55	CrCbGaD
Vincristine—TUBB6—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.000313	0.151	CbGdCrCtD
Vincristine—TUBB6—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.000313	0.151	CbGdCrCtD
Vincristine—Vinorelbine—ABCB1—peripheral nervous system neoplasm	0.000281	0.254	CrCbGaD
Vincristine—SLC22A3—tongue—peripheral nervous system neoplasm	0.000277	0.0497	CbGeAlD
Vincristine—TUBA4A—trigeminal ganglion—peripheral nervous system neoplasm	0.000255	0.0458	CbGeAlD
Vincristine—TUBA4A—parotid gland—peripheral nervous system neoplasm	0.000241	0.0432	CbGeAlD
Vincristine—RALBP1—trigeminal ganglion—peripheral nervous system neoplasm	0.00024	0.0431	CbGeAlD
Vincristine—TUBB6—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.115	CbGdCrCtD
Vincristine—RALBP1—parotid gland—peripheral nervous system neoplasm	0.000227	0.0407	CbGeAlD
Vincristine—TUBA4A—brainstem—peripheral nervous system neoplasm	0.000226	0.0405	CbGeAlD
Vincristine—TUBB6—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000219	0.106	CbGdCrCtD
Vincristine—TUBB6—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000219	0.106	CbGdCrCtD
Vincristine—TUBB6—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000219	0.106	CbGdCrCtD
Vincristine—TUBB6—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000219	0.106	CbGdCrCtD
Vincristine—Vinblastine—ABCB1—peripheral nervous system neoplasm	0.000216	0.196	CrCbGaD
Vincristine—TUBB4A—trigeminal ganglion—peripheral nervous system neoplasm	0.000204	0.0367	CbGeAlD
Vincristine—TUBB2B—trigeminal ganglion—peripheral nervous system neoplasm	0.000198	0.0355	CbGeAlD
Vincristine—TUBB—trigeminal ganglion—peripheral nervous system neoplasm	0.000187	0.0336	CbGeAlD
Vincristine—TUBB2B—parotid gland—peripheral nervous system neoplasm	0.000186	0.0334	CbGeAlD
Vincristine—TUBB2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000186	0.0334	CbGeAlD
Vincristine—TUBB6—trigeminal ganglion—peripheral nervous system neoplasm	0.000183	0.0329	CbGeAlD
Vincristine—TUBB4A—brainstem—peripheral nervous system neoplasm	0.000181	0.0325	CbGeAlD
Vincristine—TUBB—parotid gland—peripheral nervous system neoplasm	0.000176	0.0316	CbGeAlD
Vincristine—TUBB2A—parotid gland—peripheral nervous system neoplasm	0.000175	0.0315	CbGeAlD
Vincristine—TUBB6—parotid gland—peripheral nervous system neoplasm	0.000173	0.031	CbGeAlD
Vincristine—TUBB6—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.0801	CbGdCrCtD
Vincristine—TUBB6—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.0801	CbGdCrCtD
Vincristine—ABCC10—trigeminal ganglion—peripheral nervous system neoplasm	0.000161	0.0288	CbGeAlD
Vincristine—TUBB4B—trigeminal ganglion—peripheral nervous system neoplasm	0.000159	0.0286	CbGeAlD
Vincristine—ABCC10—parotid gland—peripheral nervous system neoplasm	0.000152	0.0272	CbGeAlD
Vincristine—TUBB4B—parotid gland—peripheral nervous system neoplasm	0.00015	0.027	CbGeAlD
Vincristine—TUBB3—cerebellum—peripheral nervous system neoplasm	0.000147	0.0263	CbGeAlD
Vincristine—SLC22A3—trigeminal ganglion—peripheral nervous system neoplasm	0.000137	0.0247	CbGeAlD
Vincristine—SLC22A3—parotid gland—peripheral nervous system neoplasm	0.00013	0.0233	CbGeAlD
Vincristine—TUBA4A—cerebellum—peripheral nervous system neoplasm	0.000111	0.02	CbGeAlD
Vincristine—ABCC1—parotid gland—peripheral nervous system neoplasm	0.000107	0.0192	CbGeAlD
Vincristine—RALBP1—cerebellum—peripheral nervous system neoplasm	0.000105	0.0188	CbGeAlD
Vincristine—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	9.41e-05	0.0169	CbGeAlD
Vincristine—TUBB4A—cerebellum—peripheral nervous system neoplasm	8.92e-05	0.016	CbGeAlD
Vincristine—ABCG2—parotid gland—peripheral nervous system neoplasm	8.87e-05	0.0159	CbGeAlD
Vincristine—TUBB2B—cerebellum—peripheral nervous system neoplasm	8.62e-05	0.0155	CbGeAlD
Vincristine—TUBB—cerebellum—peripheral nervous system neoplasm	8.16e-05	0.0146	CbGeAlD
Vincristine—TUBB2A—cerebellum—peripheral nervous system neoplasm	8.12e-05	0.0146	CbGeAlD
Vincristine—TUBB6—cerebellum—peripheral nervous system neoplasm	8.01e-05	0.0144	CbGeAlD
Vincristine—ABCC10—cerebellum—peripheral nervous system neoplasm	7.01e-05	0.0126	CbGeAlD
Vincristine—TUBB4B—cerebellum—peripheral nervous system neoplasm	6.96e-05	0.0125	CbGeAlD
Vincristine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	6.75e-05	0.000793	CcSEcCtD
Vincristine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	6.74e-05	0.000792	CcSEcCtD
Vincristine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	6.74e-05	0.000791	CcSEcCtD
Vincristine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	6.69e-05	0.000786	CcSEcCtD
Vincristine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	6.69e-05	0.000786	CcSEcCtD
Vincristine—Alopecia—Etoposide—peripheral nervous system neoplasm	6.68e-05	0.000785	CcSEcCtD
Vincristine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	6.65e-05	0.000781	CcSEcCtD
Vincristine—Anaemia—Cisplatin—peripheral nervous system neoplasm	6.64e-05	0.00078	CcSEcCtD
Vincristine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	6.6e-05	0.000775	CcSEcCtD
Vincristine—Asthenia—Topotecan—peripheral nervous system neoplasm	6.57e-05	0.000771	CcSEcCtD
Vincristine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	6.56e-05	0.00077	CcSEcCtD
Vincristine—Asthenia—Tretinoin—peripheral nervous system neoplasm	6.51e-05	0.000765	CcSEcCtD
Vincristine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	6.51e-05	0.000765	CcSEcCtD
Vincristine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	6.45e-05	0.000758	CcSEcCtD
Vincristine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	6.43e-05	0.000755	CcSEcCtD
Vincristine—Asthenia—Melphalan—peripheral nervous system neoplasm	6.43e-05	0.000755	CcSEcCtD
Vincristine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	6.43e-05	0.000755	CcSEcCtD
Vincristine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	6.4e-05	0.000751	CcSEcCtD
Vincristine—Back pain—Etoposide—peripheral nervous system neoplasm	6.37e-05	0.000748	CcSEcCtD
Vincristine—Pain—Dactinomycin—peripheral nervous system neoplasm	6.35e-05	0.000745	CcSEcCtD
Vincristine—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	6.31e-05	0.000741	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	6.27e-05	0.000736	CcSEcCtD
Vincristine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	6.26e-05	0.000735	CcSEcCtD
Vincristine—Convulsion—Cisplatin—peripheral nervous system neoplasm	6.22e-05	0.000731	CcSEcCtD
Vincristine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	6.22e-05	0.000731	CcSEcCtD
Vincristine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	6.21e-05	0.00073	CcSEcCtD
Vincristine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	6.21e-05	0.00073	CcSEcCtD
Vincristine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	6.18e-05	0.000726	CcSEcCtD
Vincristine—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000722	CcSEcCtD
Vincristine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	6.13e-05	0.00072	CcSEcCtD
Vincristine—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000719	CcSEcCtD
Vincristine—Myalgia—Cisplatin—peripheral nervous system neoplasm	6.12e-05	0.000718	CcSEcCtD
Vincristine—Anaemia—Etoposide—peripheral nervous system neoplasm	6.08e-05	0.000714	CcSEcCtD
Vincristine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	6.07e-05	0.000713	CcSEcCtD
Vincristine—Dizziness—Topotecan—peripheral nervous system neoplasm	6.05e-05	0.000711	CcSEcCtD
Vincristine—Dizziness—Tretinoin—peripheral nervous system neoplasm	6e-05	0.000705	CcSEcCtD
Vincristine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	6e-05	0.000705	CcSEcCtD
Vincristine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	5.98e-05	0.000703	CcSEcCtD
Vincristine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	5.94e-05	0.000698	CcSEcCtD
Vincristine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	5.93e-05	0.000697	CcSEcCtD
Vincristine—Vertigo—Etoposide—peripheral nervous system neoplasm	5.91e-05	0.000694	CcSEcCtD
Vincristine—Leukopenia—Etoposide—peripheral nervous system neoplasm	5.89e-05	0.000692	CcSEcCtD
Vincristine—Pain—Alitretinoin—peripheral nervous system neoplasm	5.88e-05	0.000691	CcSEcCtD
Vincristine—Constipation—Alitretinoin—peripheral nervous system neoplasm	5.88e-05	0.000691	CcSEcCtD
Vincristine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	5.87e-05	0.000689	CcSEcCtD
Vincristine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	5.87e-05	0.000689	CcSEcCtD
Vincristine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	5.86e-05	0.000689	CcSEcCtD
Vincristine—Oedema—Cisplatin—peripheral nervous system neoplasm	5.86e-05	0.000689	CcSEcCtD
Vincristine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	5.82e-05	0.000684	CcSEcCtD
Vincristine—Infection—Cisplatin—peripheral nervous system neoplasm	5.82e-05	0.000684	CcSEcCtD
Vincristine—Vomiting—Topotecan—peripheral nervous system neoplasm	5.82e-05	0.000683	CcSEcCtD
Vincristine—Vomiting—Tretinoin—peripheral nervous system neoplasm	5.77e-05	0.000678	CcSEcCtD
Vincristine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	5.77e-05	0.000678	CcSEcCtD
Vincristine—Rash—Topotecan—peripheral nervous system neoplasm	5.77e-05	0.000678	CcSEcCtD
Vincristine—Dermatitis—Topotecan—peripheral nervous system neoplasm	5.76e-05	0.000677	CcSEcCtD
Vincristine—Ataxia—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.000677	CcSEcCtD
Vincristine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	5.75e-05	0.000675	CcSEcCtD
Vincristine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	5.74e-05	0.000674	CcSEcCtD
Vincristine—Headache—Topotecan—peripheral nervous system neoplasm	5.73e-05	0.000673	CcSEcCtD
Vincristine—Rash—Tretinoin—peripheral nervous system neoplasm	5.72e-05	0.000672	CcSEcCtD
Vincristine—Rash—Isotretinoin—peripheral nervous system neoplasm	5.72e-05	0.000672	CcSEcCtD
Vincristine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	5.72e-05	0.000672	CcSEcCtD
Vincristine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	5.72e-05	0.000672	CcSEcCtD
Vincristine—Convulsion—Etoposide—peripheral nervous system neoplasm	5.7e-05	0.00067	CcSEcCtD
Vincristine—Vomiting—Melphalan—peripheral nervous system neoplasm	5.7e-05	0.000669	CcSEcCtD
Vincristine—Dehydration—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000669	CcSEcCtD
Vincristine—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000668	CcSEcCtD
Vincristine—Headache—Isotretinoin—peripheral nervous system neoplasm	5.69e-05	0.000668	CcSEcCtD
Vincristine—Headache—Tretinoin—peripheral nervous system neoplasm	5.69e-05	0.000668	CcSEcCtD
Vincristine—Hypertension—Etoposide—peripheral nervous system neoplasm	5.68e-05	0.000667	CcSEcCtD
Vincristine—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000666	CcSEcCtD
Vincristine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	5.67e-05	0.000666	CcSEcCtD
Vincristine—Rash—Melphalan—peripheral nervous system neoplasm	5.65e-05	0.000664	CcSEcCtD
Vincristine—Dermatitis—Melphalan—peripheral nervous system neoplasm	5.64e-05	0.000663	CcSEcCtD
Vincristine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	5.63e-05	0.000661	CcSEcCtD
Vincristine—Anorexia—Cisplatin—peripheral nervous system neoplasm	5.59e-05	0.000656	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	5.52e-05	0.000648	CcSEcCtD
Vincristine—Hypotension—Cisplatin—peripheral nervous system neoplasm	5.48e-05	0.000643	CcSEcCtD
Vincristine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	5.47e-05	0.000642	CcSEcCtD
Vincristine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	5.44e-05	0.000639	CcSEcCtD
Vincristine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	5.44e-05	0.000639	CcSEcCtD
Vincristine—Nausea—Topotecan—peripheral nervous system neoplasm	5.44e-05	0.000639	CcSEcCtD
Vincristine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	5.4e-05	0.000635	CcSEcCtD
Vincristine—Nausea—Tretinoin—peripheral nervous system neoplasm	5.39e-05	0.000633	CcSEcCtD
Vincristine—Nausea—Isotretinoin—peripheral nervous system neoplasm	5.39e-05	0.000633	CcSEcCtD
Vincristine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	5.39e-05	0.000633	CcSEcCtD
Vincristine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	5.37e-05	0.000631	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	5.34e-05	0.000627	CcSEcCtD
Vincristine—Infection—Etoposide—peripheral nervous system neoplasm	5.34e-05	0.000627	CcSEcCtD
Vincristine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000626	CcSEcCtD
Vincristine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	5.32e-05	0.000625	CcSEcCtD
Vincristine—Nausea—Melphalan—peripheral nervous system neoplasm	5.32e-05	0.000625	CcSEcCtD
Vincristine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.000619	CcSEcCtD
Vincristine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	5.26e-05	0.000618	CcSEcCtD
Vincristine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	5.26e-05	0.000618	CcSEcCtD
Vincristine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	5.19e-05	0.00061	CcSEcCtD
Vincristine—Anorexia—Etoposide—peripheral nervous system neoplasm	5.12e-05	0.000601	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000599	CcSEcCtD
Vincristine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	5.1e-05	0.000599	CcSEcCtD
Vincristine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	5.08e-05	0.000596	CcSEcCtD
Vincristine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	5.07e-05	0.000595	CcSEcCtD
Vincristine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	5.06e-05	0.000594	CcSEcCtD
Vincristine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000591	CcSEcCtD
Vincristine—Hypotension—Etoposide—peripheral nervous system neoplasm	5.02e-05	0.000589	CcSEcCtD
Vincristine—Pain—Cisplatin—peripheral nervous system neoplasm	5.01e-05	0.000589	CcSEcCtD
Vincristine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.000587	CcSEcCtD
Vincristine—ABCC1—cerebellum—peripheral nervous system neoplasm	4.96e-05	0.00889	CbGeAlD
Vincristine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.000581	CcSEcCtD
Vincristine—Dysuria—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.000581	CcSEcCtD
Vincristine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	4.94e-05	0.00058	CcSEcCtD
Vincristine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000568	CcSEcCtD
Vincristine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	4.82e-05	0.000566	CcSEcCtD
Vincristine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000563	CcSEcCtD
Vincristine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000558	CcSEcCtD
Vincristine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	4.72e-05	0.000554	CcSEcCtD
Vincristine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	4.71e-05	0.000553	CcSEcCtD
Vincristine—Rash—Dactinomycin—peripheral nervous system neoplasm	4.68e-05	0.00055	CcSEcCtD
Vincristine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	4.67e-05	0.000548	CcSEcCtD
Vincristine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000546	CcSEcCtD
Vincristine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	4.64e-05	0.00832	CbGeAlD
Vincristine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	4.64e-05	0.000545	CcSEcCtD
Vincristine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	4.63e-05	0.000544	CcSEcCtD
Vincristine—Fatigue—Etoposide—peripheral nervous system neoplasm	4.63e-05	0.000544	CcSEcCtD
Vincristine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.000543	CcSEcCtD
Vincristine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.00054	CcSEcCtD
Vincristine—Constipation—Etoposide—peripheral nervous system neoplasm	4.59e-05	0.000539	CcSEcCtD
Vincristine—Pain—Etoposide—peripheral nervous system neoplasm	4.59e-05	0.000539	CcSEcCtD
Vincristine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000538	CcSEcCtD
Vincristine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000538	CcSEcCtD
Vincristine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.55e-05	0.000534	CcSEcCtD
Vincristine—Sweating—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000532	CcSEcCtD
Vincristine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000525	CcSEcCtD
Vincristine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000521	CcSEcCtD
Vincristine—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.41e-05	0.000518	CcSEcCtD
Vincristine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000516	CcSEcCtD
Vincristine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.39e-05	0.000516	CcSEcCtD
Vincristine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.37e-05	0.000514	CcSEcCtD
Vincristine—Rash—Alitretinoin—peripheral nervous system neoplasm	4.34e-05	0.00051	CcSEcCtD
Vincristine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.33e-05	0.000509	CcSEcCtD
Vincristine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.32e-05	0.000507	CcSEcCtD
Vincristine—Headache—Alitretinoin—peripheral nervous system neoplasm	4.31e-05	0.000506	CcSEcCtD
Vincristine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.000503	CcSEcCtD
Vincristine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.0005	CcSEcCtD
Vincristine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.25e-05	0.000499	CcSEcCtD
Vincristine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.25e-05	0.000499	CcSEcCtD
Vincristine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.22e-05	0.000495	CcSEcCtD
Vincristine—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.21e-05	0.000494	CcSEcCtD
Vincristine—Sweating—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000492	CcSEcCtD
Vincristine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.000492	CcSEcCtD
Vincristine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000489	CcSEcCtD
Vincristine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000488	CcSEcCtD
Vincristine—ABCG2—cerebellum—peripheral nervous system neoplasm	4.1e-05	0.00736	CbGeAlD
Vincristine—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.09e-05	0.00048	CcSEcCtD
Vincristine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.01e-05	0.000471	CcSEcCtD
Vincristine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	3.96e-05	0.000465	CcSEcCtD
Vincristine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.000462	CcSEcCtD
Vincristine—ABCC3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.93e-05	0.00178	CbGpPWpGaD
Vincristine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	3.9e-05	0.000458	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	3.88e-05	0.00176	CbGpPWpGaD
Vincristine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000455	CcSEcCtD
Vincristine—Asthenia—Etoposide—peripheral nervous system neoplasm	3.85e-05	0.000453	CcSEcCtD
Vincristine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000453	CcSEcCtD
Vincristine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	3.84e-05	0.000452	CcSEcCtD
Vincristine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000451	CcSEcCtD
Vincristine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	3.82e-05	0.000449	CcSEcCtD
Vincristine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	3.81e-05	0.00173	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—AURKA—peripheral nervous system neoplasm	3.8e-05	0.00172	CbGpPWpGaD
Vincristine—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	3.79e-05	0.00172	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.78e-05	0.00171	CbGpPWpGaD
Vincristine—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.00044	CcSEcCtD
Vincristine—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.73e-05	0.000438	CcSEcCtD
Vincristine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	3.71e-05	0.000436	CcSEcCtD
Vincristine—Rash—Cisplatin—peripheral nervous system neoplasm	3.7e-05	0.000434	CcSEcCtD
Vincristine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.69e-05	0.000434	CcSEcCtD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	3.69e-05	0.00167	CbGpPWpGaD
Vincristine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.67e-05	0.000432	CcSEcCtD
Vincristine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	3.64e-05	0.000427	CcSEcCtD
Vincristine—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	3.64e-05	0.00165	CbGpPWpGaD
Vincristine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.63e-05	0.00165	CbGpPWpGaD
Vincristine—TUBA4A—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	3.63e-05	0.00164	CbGpPWpGaD
Vincristine—Back pain—Epirubicin—peripheral nervous system neoplasm	3.57e-05	0.000419	CcSEcCtD
Vincristine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	0.000418	CcSEcCtD
Vincristine—Dizziness—Etoposide—peripheral nervous system neoplasm	3.55e-05	0.000417	CcSEcCtD
Vincristine—TUBA4A—Hemostasis—GNAS—peripheral nervous system neoplasm	3.54e-05	0.0016	CbGpPWpGaD
Vincristine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.53e-05	0.000415	CcSEcCtD
Vincristine—TUBB4A—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	3.52e-05	0.00159	CbGpPWpGaD
Vincristine—Nausea—Cisplatin—peripheral nervous system neoplasm	3.48e-05	0.000409	CcSEcCtD
Vincristine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000407	CcSEcCtD
Vincristine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.000403	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	3.43e-05	0.00155	CbGpPWpGaD
Vincristine—Vomiting—Etoposide—peripheral nervous system neoplasm	3.41e-05	0.000401	CcSEcCtD
Vincristine—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.0004	CcSEcCtD
Vincristine—TUBB—Cell Cycle—CHEK2—peripheral nervous system neoplasm	3.39e-05	0.00154	CbGpPWpGaD
Vincristine—Agitation—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000398	CcSEcCtD
Vincristine—Rash—Etoposide—peripheral nervous system neoplasm	3.39e-05	0.000398	CcSEcCtD
Vincristine—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.38e-05	0.000397	CcSEcCtD
Vincristine—TUBA4A—Hemostasis—HGF—peripheral nervous system neoplasm	3.37e-05	0.00153	CbGpPWpGaD
Vincristine—Headache—Etoposide—peripheral nervous system neoplasm	3.36e-05	0.000395	CcSEcCtD
Vincristine—RALBP1—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.34e-05	0.00151	CbGpPWpGaD
Vincristine—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000389	CcSEcCtD
Vincristine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.3e-05	0.000388	CcSEcCtD
Vincristine—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000388	CcSEcCtD
Vincristine—TUBB6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.27e-05	0.00148	CbGpPWpGaD
Vincristine—TUBB2B—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.27e-05	0.00148	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	3.24e-05	0.00147	CbGpPWpGaD
Vincristine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.23e-05	0.00146	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	3.22e-05	0.00146	CbGpPWpGaD
Vincristine—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000375	CcSEcCtD
Vincristine—Nausea—Etoposide—peripheral nervous system neoplasm	3.19e-05	0.000375	CcSEcCtD
Vincristine—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.18e-05	0.000374	CcSEcCtD
Vincristine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000371	CcSEcCtD
Vincristine—TUBB3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.15e-05	0.00143	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—AURKA—peripheral nervous system neoplasm	3.15e-05	0.00143	CbGpPWpGaD
Vincristine—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000369	CcSEcCtD
Vincristine—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.14e-05	0.000368	CcSEcCtD
Vincristine—TUBB6—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	3.11e-05	0.00141	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	3.11e-05	0.00141	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.08e-05	0.0014	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.08e-05	0.00139	CbGpPWpGaD
Vincristine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.00036	CcSEcCtD
Vincristine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.06e-05	0.000359	CcSEcCtD
Vincristine—TUBB2A—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.05e-05	0.00138	CbGpPWpGaD
Vincristine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	3.01e-05	0.000354	CcSEcCtD
Vincristine—Oedema—Epirubicin—peripheral nervous system neoplasm	3.01e-05	0.000354	CcSEcCtD
Vincristine—TUBB3—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	3e-05	0.00136	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3e-05	0.00136	CbGpPWpGaD
Vincristine—Infection—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000351	CcSEcCtD
Vincristine—TUBB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.99e-05	0.00135	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.96e-05	0.00134	CbGpPWpGaD
Vincristine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000347	CcSEcCtD
Vincristine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	2.95e-05	0.000347	CcSEcCtD
Vincristine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.95e-05	0.000346	CcSEcCtD
Vincristine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.000346	CcSEcCtD
Vincristine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.91e-05	0.000342	CcSEcCtD
Vincristine—TUBB2A—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	2.91e-05	0.00132	CbGpPWpGaD
Vincristine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.000341	CcSEcCtD
Vincristine—TUBA4A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	2.89e-05	0.00131	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.89e-05	0.00131	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—AURKA—peripheral nervous system neoplasm	2.88e-05	0.0013	CbGpPWpGaD
Vincristine—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.87e-05	0.000337	CcSEcCtD
Vincristine—TUBB1—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	2.85e-05	0.00129	CbGpPWpGaD
Vincristine—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.81e-05	0.00033	CcSEcCtD
Vincristine—TUBB4A—Cell Cycle—CHEK2—peripheral nervous system neoplasm	2.81e-05	0.00127	CbGpPWpGaD
Vincristine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.79e-05	0.000327	CcSEcCtD
Vincristine—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.79e-05	0.000327	CcSEcCtD
Vincristine—Infection—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000325	CcSEcCtD
Vincristine—ABCB11—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.77e-05	0.00125	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	2.75e-05	0.00125	CbGpPWpGaD
Vincristine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.74e-05	0.000322	CcSEcCtD
Vincristine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.73e-05	0.000321	CcSEcCtD
Vincristine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.73e-05	0.00032	CcSEcCtD
Vincristine—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.72e-05	0.00032	CcSEcCtD
Vincristine—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.71e-05	0.00123	CbGpPWpGaD
Vincristine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.7e-05	0.000318	CcSEcCtD
Vincristine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.69e-05	0.000316	CcSEcCtD
Vincristine—CYP3A7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.68e-05	0.00122	CbGpPWpGaD
Vincristine—TUBB4A—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.68e-05	0.00122	CbGpPWpGaD
Vincristine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.66e-05	0.000312	CcSEcCtD
Vincristine—ABCC3—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.65e-05	0.0012	CbGpPWpGaD
Vincristine—TUBB2B—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.63e-05	0.00119	CbGpPWpGaD
Vincristine—TUBB6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.63e-05	0.00119	CbGpPWpGaD
Vincristine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000307	CcSEcCtD
Vincristine—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.61e-05	0.00118	CbGpPWpGaD
Vincristine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.6e-05	0.000306	CcSEcCtD
Vincristine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000305	CcSEcCtD
Vincristine—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000305	CcSEcCtD
Vincristine—TUBB2B—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.58e-05	0.00117	CbGpPWpGaD
Vincristine—TUBB6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.58e-05	0.00117	CbGpPWpGaD
Vincristine—Constipation—Epirubicin—peripheral nervous system neoplasm	2.57e-05	0.000302	CcSEcCtD
Vincristine—Pain—Epirubicin—peripheral nervous system neoplasm	2.57e-05	0.000302	CcSEcCtD
Vincristine—TUBB4B—Cell Cycle—CHEK2—peripheral nervous system neoplasm	2.57e-05	0.00117	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	2.55e-05	0.00116	CbGpPWpGaD
Vincristine—TUBB3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.54e-05	0.00115	CbGpPWpGaD
Vincristine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.54e-05	0.000298	CcSEcCtD
Vincristine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.52e-05	0.000296	CcSEcCtD
Vincristine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	0.000294	CcSEcCtD
Vincristine—TUBB3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.49e-05	0.00113	CbGpPWpGaD
Vincristine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.46e-05	0.000289	CcSEcCtD
Vincristine—TUBB—Cell Cycle—BIRC5—peripheral nervous system neoplasm	2.46e-05	0.00112	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.46e-05	0.00111	CbGpPWpGaD
Vincristine—TUBB2A—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.46e-05	0.00111	CbGpPWpGaD
Vincristine—TUBB4B—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.45e-05	0.00111	CbGpPWpGaD
Vincristine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.42e-05	0.000284	CcSEcCtD
Vincristine—TUBB2A—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.41e-05	0.00109	CbGpPWpGaD
Vincristine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000282	CcSEcCtD
Vincristine—TUBB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.4e-05	0.00109	CbGpPWpGaD
Vincristine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000282	CcSEcCtD
Vincristine—Pain—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	0.00028	CcSEcCtD
Vincristine—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	0.00028	CcSEcCtD
Vincristine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.38e-05	0.00028	CcSEcCtD
Vincristine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.38e-05	0.00028	CcSEcCtD
Vincristine—TUBB1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.36e-05	0.00107	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	2.34e-05	0.00106	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.31e-05	0.00105	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.3e-05	0.00104	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	2.28e-05	0.00103	CbGpPWpGaD
Vincristine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.28e-05	0.000268	CcSEcCtD
Vincristine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.22e-05	0.000261	CcSEcCtD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.2e-05	0.000999	CbGpPWpGaD
Vincristine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.2e-05	0.000259	CcSEcCtD
Vincristine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.2e-05	0.000259	CcSEcCtD
Vincristine—SLC22A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.18e-05	0.000986	CbGpPWpGaD
Vincristine—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.16e-05	0.000254	CcSEcCtD
Vincristine—TUBB4A—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.16e-05	0.000978	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	2.14e-05	0.000972	CbGpPWpGaD
Vincristine—TUBB4A—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.12e-05	0.00096	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GNS—peripheral nervous system neoplasm	2.09e-05	0.000946	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	2.09e-05	0.000945	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.08e-05	0.000942	CbGpPWpGaD
Vincristine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.06e-05	0.000242	CcSEcCtD
Vincristine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.05e-05	0.000241	CcSEcCtD
Vincristine—TUBB4A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	2.04e-05	0.000924	CbGpPWpGaD
Vincristine—ABCB1—cerebellum—peripheral nervous system neoplasm	2.02e-05	0.00363	CbGeAlD
Vincristine—NR0B1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	2.02e-05	0.000917	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—NME1—peripheral nervous system neoplasm	2e-05	0.000907	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GNS—peripheral nervous system neoplasm	2e-05	0.000907	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2e-05	0.000906	CbGpPWpGaD
Vincristine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2e-05	0.000235	CcSEcCtD
Vincristine—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.99e-05	0.000234	CcSEcCtD
Vincristine—RALBP1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.98e-05	0.000897	CbGpPWpGaD
Vincristine—TUBB4B—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.97e-05	0.000895	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.94e-05	0.000879	CbGpPWpGaD
Vincristine—TUBB4B—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.94e-05	0.000878	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—COX2—peripheral nervous system neoplasm	1.93e-05	0.000873	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—NME1—peripheral nervous system neoplasm	1.92e-05	0.000869	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GNS—peripheral nervous system neoplasm	1.92e-05	0.000869	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.92e-05	0.000869	CbGpPWpGaD
Vincristine—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.91e-05	0.000225	CcSEcCtD
Vincristine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.91e-05	0.000224	CcSEcCtD
Vincristine—Rash—Epirubicin—peripheral nervous system neoplasm	1.9e-05	0.000223	CcSEcCtD
Vincristine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.9e-05	0.000223	CcSEcCtD
Vincristine—RALBP1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.89e-05	0.000855	CbGpPWpGaD
Vincristine—Headache—Epirubicin—peripheral nervous system neoplasm	1.89e-05	0.000222	CcSEcCtD
Vincristine—TUBB4B—Cell Cycle—BIRC5—peripheral nervous system neoplasm	1.86e-05	0.000845	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.85e-05	0.00084	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—COX2—peripheral nervous system neoplasm	1.85e-05	0.000837	CbGpPWpGaD
Vincristine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.84e-05	0.000216	CcSEcCtD
Vincristine—ABCC3—Metabolism—NME1—peripheral nervous system neoplasm	1.84e-05	0.000833	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.83e-05	0.000829	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	1.82e-05	0.000827	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.81e-05	0.000822	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.81e-05	0.000819	CbGpPWpGaD
Vincristine—ABCC1—Disease—GNS—peripheral nervous system neoplasm	1.79e-05	0.000813	CbGpPWpGaD
Vincristine—Nausea—Epirubicin—peripheral nervous system neoplasm	1.79e-05	0.00021	CcSEcCtD
Vincristine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.77e-05	0.000208	CcSEcCtD
Vincristine—ABCC3—Metabolism—COX2—peripheral nervous system neoplasm	1.77e-05	0.000802	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.76e-05	0.0008	CbGpPWpGaD
Vincristine—Rash—Doxorubicin—peripheral nervous system neoplasm	1.76e-05	0.000206	CcSEcCtD
Vincristine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.75e-05	0.000206	CcSEcCtD
Vincristine—SLC22A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.75e-05	0.000793	CbGpPWpGaD
Vincristine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.75e-05	0.000791	CbGpPWpGaD
Vincristine—Headache—Doxorubicin—peripheral nervous system neoplasm	1.75e-05	0.000205	CcSEcCtD
Vincristine—RALBP1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.73e-05	0.000784	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.73e-05	0.000783	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.72e-05	0.000778	CbGpPWpGaD
Vincristine—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.65e-05	0.000194	CcSEcCtD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.65e-05	0.000746	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.63e-05	0.000739	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.61e-05	0.000729	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.59e-05	0.000719	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.58e-05	0.000716	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.57e-05	0.00071	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.53e-05	0.000692	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	1.51e-05	0.000685	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.51e-05	0.000683	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	1.5e-05	0.000681	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.48e-05	0.00067	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.46e-05	0.000664	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.45e-05	0.000659	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	1.44e-05	0.000653	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.41e-05	0.000638	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	1.39e-05	0.000629	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	1.38e-05	0.000626	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.38e-05	0.000625	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.35e-05	0.000612	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	1.32e-05	0.000599	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	1.31e-05	0.000594	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.31e-05	0.000594	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MYC—peripheral nervous system neoplasm	1.3e-05	0.000589	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.28e-05	0.000578	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.27e-05	0.000575	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ENO2—peripheral nervous system neoplasm	1.26e-05	0.000573	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.26e-05	0.000571	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	1.26e-05	0.00057	CbGpPWpGaD
Vincristine—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	1.26e-05	0.000569	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.25e-05	0.000567	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.24e-05	0.000561	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.24e-05	0.00056	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.24e-05	0.00056	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.22e-05	0.000553	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	1.21e-05	0.000549	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	1.21e-05	0.000548	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.2e-05	0.000545	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	1.16e-05	0.000527	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TP53—peripheral nervous system neoplasm	1.13e-05	0.000513	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.11e-05	0.000503	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MYC—peripheral nervous system neoplasm	1.11e-05	0.000501	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.09e-05	0.000493	CbGpPWpGaD
Vincristine—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	1.09e-05	0.000493	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.08e-05	0.00049	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—BCHE—peripheral nervous system neoplasm	1.07e-05	0.000484	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TP53—peripheral nervous system neoplasm	1.07e-05	0.000484	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	1.02e-05	0.000464	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.02e-05	0.000464	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.02e-05	0.000462	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—TH—peripheral nervous system neoplasm	1e-05	0.000455	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.89e-06	0.000448	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	9.82e-06	0.000445	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.77e-06	0.000443	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—MYC—peripheral nervous system neoplasm	9.74e-06	0.000441	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	9.63e-06	0.000436	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—AKT1—peripheral nervous system neoplasm	9.55e-06	0.000433	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	9.54e-06	0.000432	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.5e-06	0.000431	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	9.47e-06	0.000429	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.37e-06	0.000425	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	9.37e-06	0.000425	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	9.23e-06	0.000418	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MYC—peripheral nervous system neoplasm	9.16e-06	0.000415	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	9.1e-06	0.000413	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	9.08e-06	0.000412	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TP53—peripheral nervous system neoplasm	9.07e-06	0.000411	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.02e-06	0.000409	CbGpPWpGaD
Vincristine—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	8.76e-06	0.000397	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	8.74e-06	0.000396	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.63e-06	0.000391	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MYC—peripheral nervous system neoplasm	8.37e-06	0.00038	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	8.3e-06	0.000376	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GNAS—peripheral nervous system neoplasm	8.2e-06	0.000372	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ABCB1—peripheral nervous system neoplasm	8.04e-06	0.000365	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	8.01e-06	0.000363	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	7.94e-06	0.00036	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	7.86e-06	0.000356	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	7.71e-06	0.00035	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	7.69e-06	0.000349	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	7.54e-06	0.000342	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	7.53e-06	0.000341	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TP53—peripheral nervous system neoplasm	7.52e-06	0.000341	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.45e-06	0.000338	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	7.39e-06	0.000335	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.34e-06	0.000333	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	7.23e-06	0.000328	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.23e-06	0.000328	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	7.15e-06	0.000324	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TP53—peripheral nervous system neoplasm	6.88e-06	0.000312	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	6.85e-06	0.000311	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	6.77e-06	0.000307	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—AKT1—peripheral nervous system neoplasm	6.75e-06	0.000306	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.74e-06	0.000305	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	6.71e-06	0.000304	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	6.6e-06	0.000299	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.46e-06	0.000293	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.4e-06	0.00029	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	6.36e-06	0.000288	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	6.31e-06	0.000286	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.09e-06	0.000276	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6e-06	0.000272	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	5.9e-06	0.000268	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.88e-06	0.000266	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.79e-06	0.000263	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	5.74e-06	0.00026	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.53e-06	0.000251	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.29e-06	0.00024	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	5.2e-06	0.000235	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	5.15e-06	0.000233	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	5.1e-06	0.000231	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	5.05e-06	0.000229	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	4.9e-06	0.000222	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	4.85e-06	0.00022	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.83e-06	0.000219	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.67e-06	0.000212	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.63e-06	0.00021	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	4.56e-06	0.000207	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	4.4e-06	0.0002	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	4.33e-06	0.000196	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	4.22e-06	0.000191	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.08e-06	0.000185	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	4.06e-06	0.000184	CbGpPWpGaD
Vincristine—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	3.87e-06	0.000176	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	3.72e-06	0.000169	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	3.66e-06	0.000166	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	3.65e-06	0.000166	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.49e-06	0.000158	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	3.44e-06	0.000156	CbGpPWpGaD
Vincristine—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	2.95e-06	0.000134	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	2.81e-06	0.000127	CbGpPWpGaD
Vincristine—ABCC1—Disease—MYC—peripheral nervous system neoplasm	2.74e-06	0.000124	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.67e-06	0.000121	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.25e-06	0.000102	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	2.21e-06	0.0001	CbGpPWpGaD
Vincristine—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	2.16e-06	9.77e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.15e-06	9.75e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	2.12e-06	9.62e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.12e-06	9.61e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	2.03e-06	9.22e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	1.9e-06	8.63e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.73e-06	7.84e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.7e-06	7.7e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	1.59e-06	7.22e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	1.4e-06	6.36e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	1.39e-06	6.3e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1e-06	4.55e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	7.58e-07	3.44e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	4.67e-07	2.12e-05	CbGpPWpGaD
